Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study)

PURPOSE: In Estonia, during the first wave of COVID-19 total number of cases confirmed by PCR was 13.3/10,000, similar in most regions, including capital Tallinn, but in the hotspot of Estonian epidemic, an island Saaremaa, the cumulative incidence was 166.1/10,000. We aimed to determine the prevale...

Descripción completa

Detalles Bibliográficos
Autores principales: Jõgi, Piia, Soeorg, Hiie, Ingerainen, Diana, Soots, Mari, Lättekivi, Freddy, Naaber, Paul, Toompere, Karolin, Peterson, Pärt, Haljasmägi, Liis, Žusinaite, Eva, Vaas, Hannes, Pauskar, Merit, Shablinskaja, Arina, Kaarna, Katrin, Paluste, Heli, Kisand, Kai, Oona, Marje, Janno, Riina, Lutsar, Irja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339569/
https://www.ncbi.nlm.nih.gov/pubmed/34393019
http://dx.doi.org/10.1016/j.vaccine.2021.07.093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339569/
https://www.ncbi.nlm.nih.gov/pubmed/34393019
http://dx.doi.org/10.1016/j.vaccine.2021.07.093

Ejemplares similares